1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
Lupin Ltd. NSE: LUPIN | BSE: 500257

Lupin Ltd. Live Share Price Today, Share Analysis and Chart

Falling Comet
about

Established in 1968, Lupin is a global pharmaceutical company focused on developing and distributing a diverse range of healthcare products. Its portfolio includes generics, branded generics, complex generics, APIs, biosimilars, and specialty medicin...

Read More
1894.70 -0.10 (-0.01%)
1.5M
NSE+BSE Volume

NSE 11 Jul, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Signs Deal
Lupin partners with Zentiva to market biosimilar Certolizumab Pegol globally in a $60 mn deal See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
70.0 / 100
Valuation Score
Mid Valuation
45.7 / 100
Momentum Score
Technically Bearish
31.4 / 100
Falling Comet These stocks are the ones with good quality and mid-range financial aspects. However, their weak technical aspect reduces the investor's interest. View Similar Embed DVM
Analyst Price Target
2,235
1Yr Price target upside is 18%
36 analysts

15

S

9

W

5

O

1

T

SWOT Analysis

Lupin Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Lupin Ltd. worth buying?
920 Votes:
Buy 72.83%
Sell 17.5%
Hold 9.67%
BUY
SELL
HOLD